Julia Kennedy-Darling is a patent agent in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she focuses on patent prosecution and other IP due diligence matters. She has experience in chemical biology, in vitro DNA assay development, spatial biology, mass spectrometry, and immunology.
Prior to joining the firm, Julia was the vice president of Innovation at Akoya Biosciences, Inc., where she led new product development efforts. She was one of the inventors of the founding technology and joined the company at its inception. During her time at the company, she helped launch numerous products and initiated multiple new programs.
Julia was a Cancer Research Institute (CRI) postdoctoral fellow in the lab of Garry Nolan at Stanford University’s School of Medicine. She focused on new technology developments related to spatial biology as well as various immunology applications. Julia received her Ph.D. in the lab of Lloyd Smith at the University of Wisconsin-Madison and studied mass spectrometry proteomics and DNA capture assays.
Julia Kennedy-Darling is a patent agent in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she focuses on patent prosecution and other IP due diligence matters. She has experience in chemical biology, in vitro DNA assay development, spatial biology, mass spectrometry, and immunology.
Prior to joining the firm, Julia was the vice president of Innovation at Akoya Biosciences, Inc., where she led new product development efforts. She was one of the inventors of the founding technology and joined the company at its inception. During her time at the company, she helped launch numerous products and initiated multiple new programs.
Julia was a Cancer Research Institute (CRI) postdoctoral fellow in the lab of Garry Nolan at Stanford University’s School of Medicine. She focused on new technology developments related to spatial biology as well as various immunology applications. Julia received her Ph.D. in the lab of Lloyd Smith at the University of Wisconsin-Madison and studied mass spectrometry proteomics and DNA capture assays.
- Ph.D., Chemistry, University of Wisconsin-Madison
- B.S., Chemistry, University of Chicago
- U.S. Patent and Trademark Office
- Ph.D., Chemistry, University of Wisconsin-Madison
- B.S., Chemistry, University of Chicago
- U.S. Patent and Trademark Office
Select Publications
- Co-author with S. Bhate, J. Hicky, S. Black, G. Barlow, G. Vasquez, V. Venkataraaman, N. Samusik, Y. Golstev, C. Schürch, and G. Nolan, “Highly multiplexed tissue imaging using repeated oligonucleotide exchange reaction,” 51 European Journal of Immunology 1262-1277, 2021
- Co-author with S. Black, D. Phillips, J. Hickey, V. Venkataraaman, N. Samusik, Y. Goltsev, M. Christian, C. Schürch, and G. Nolan, “CODEX Multiplexed Tissue Imaging with DNA-Conjugated Antibodies,” 16(8) Nature Protocols 2802-3835, 2021
- Co-author with Y. Goltsev, N. Samusik, S. Bhate, M. Hale, G. Vazquez, S. Black, and G. Nolan, “Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging,” 174 Cell 968-981, 2018
- Co-author with K. Buxton, M. Shortreed, N. Zaidan, M. Olivier, M. Scalf, R. Sridharan, and L. Smith, “Elucidating Protein–DNA Interactions in Human Alphoid Chromatin via Hybridization Capture and Mass Spectrometry,” 16(9) Proteome Research 3433-3442, 2017
- Lead author with H. Guillen-Ahlers, M. Shortreed, M. Scalf, B. Frey, C. Kendziorski, M. Olivier, A. Gasch, and L. Smith, “Discovery of Chromatin-Associated Proteins via Sequence-Specific Capture and Mass Spectrometric Protein Identification in Saccharomyces cerevisiae,” 13(8) Journal of Proteome Research 3810-3825, 2014
- Lead author with M. Holden, M. Shortreed, and L. Smith, “Multiplexed Programmable Release of Captured DNA,” 15(16) ChemBioChem. 2353-2356, 2014
- Co-author with G. Nolan, N. Samusik, and Y. Goltsev, “Highly-multiplexed fluorescent imaging,” United States Patent Office, 2019
Select Publications
- Co-author with S. Bhate, J. Hicky, S. Black, G. Barlow, G. Vasquez, V. Venkataraaman, N. Samusik, Y. Golstev, C. Schürch, and G. Nolan, “Highly multiplexed tissue imaging using repeated oligonucleotide exchange reaction,” 51 European Journal of Immunology 1262-1277, 2021
- Co-author with S. Black, D. Phillips, J. Hickey, V. Venkataraaman, N. Samusik, Y. Goltsev, M. Christian, C. Schürch, and G. Nolan, “CODEX Multiplexed Tissue Imaging with DNA-Conjugated Antibodies,” 16(8) Nature Protocols 2802-3835, 2021
- Co-author with Y. Goltsev, N. Samusik, S. Bhate, M. Hale, G. Vazquez, S. Black, and G. Nolan, “Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging,” 174 Cell 968-981, 2018
- Co-author with K. Buxton, M. Shortreed, N. Zaidan, M. Olivier, M. Scalf, R. Sridharan, and L. Smith, “Elucidating Protein–DNA Interactions in Human Alphoid Chromatin via Hybridization Capture and Mass Spectrometry,” 16(9) Proteome Research 3433-3442, 2017
- Lead author with H. Guillen-Ahlers, M. Shortreed, M. Scalf, B. Frey, C. Kendziorski, M. Olivier, A. Gasch, and L. Smith, “Discovery of Chromatin-Associated Proteins via Sequence-Specific Capture and Mass Spectrometric Protein Identification in Saccharomyces cerevisiae,” 13(8) Journal of Proteome Research 3810-3825, 2014
- Lead author with M. Holden, M. Shortreed, and L. Smith, “Multiplexed Programmable Release of Captured DNA,” 15(16) ChemBioChem. 2353-2356, 2014
- Co-author with G. Nolan, N. Samusik, and Y. Goltsev, “Highly-multiplexed fluorescent imaging,” United States Patent Office, 2019
Biological Sciences and Biotechnology
- Antibody
- Biochemical assays
- Biochemistry
- Bioconjugation
- Biologics
- Cancer biology
- Cell biology
- Cellular biology
- Cellular immunology
- Genomics
- Immuno-oncology
- Immunobiology
- PCR
Engineering and Technology
- Microfluidics
Genomics and Data Analysis
- Functional genomics
Biological Sciences and Biotechnology
- Antibody
- Biochemical assays
- Biochemistry
- Bioconjugation
- Biologics
- Cancer biology
- Cell biology
- Cellular biology
- Cellular immunology
- Genomics
- Immuno-oncology
- Immunobiology
- PCR
Engineering and Technology
- Microfluidics
Genomics and Data Analysis
- Functional genomics
The transaction combines Natera’s leading commercial and operational infrastructure for the delivery of personalized MRD testing with Foresight’s unique phased variant technology and leadership in lymphoma. It builds on Natera’s broad intellectual property portfolio for tumor-informed and personalized MRD products including in phased variants, and promises to accelerate MRD adoption in lymphoma and other solid tumor types.
- Privacy Policy
- Terms of Use
- Accessibility